Streetbeat News

Products Services

BNO

UCO

USO

Oil prices are rising due to supply uncertainty following Iran's attack on Israel.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:23 pm

VCYT

Veracyte, Inc. presented new data from the VANDAAM trial at ASTRO 2024, showing that its Decipher Prostate Genomic Classifier accurately predicts aggressive prostate cancer in African American men. This test offers an improvement over clinical factors alone in guiding treatment decisions for this disproportionately affected population.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:23 pm

SOFI

SoFi has launched DSP2.0 in collaboration with PrimaryBid to enhance U.S. IPOs and capital raises, aiming to provide individual investors with better access to public offerings.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:17 pm

SCPX

Scorpius Holdings, Inc (NYSE American: SCPX) has been selected to join the Medical CBRN Defense Consortium, which focuses on developing medical countermeasures against CBRN threats. This partnership will allow Scorpius to contribute its expertise to advance national security technologies.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:17 pm

ATYR

aTyr Pharma announced the publication of a study in the European Respiratory Journal showing the efficacy of efzofitimod in treating pulmonary sarcoidosis. The study demonstrated a significant reduction in relapse rates for patients on therapeutic doses compared to subtherapeutic doses.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:15 pm

ESPR

Esperion's European partner, Daiichi Sankyo Europe, reported positive real-world results from the MILOS study in Germany, showing significant LDL-C reduction with bempedoic acid. The study demonstrated a 7-fold increase in patients achieving LDL-C goals, confirming the drug's effectiveness and safety.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:15 pm

TCMD

Tactile Systems Technology, Inc. (NASDAQ:TCMD) has announced the commercial availability of Nimbl, its next-generation pneumatic compression platform, in the U.S. for treating upper extremity lymphedema. Nimbl is smaller and lighter than previous models and has received FDA clearance and CMS approval.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:14 pm

IMCC

IM Cannabis Corp. (NASDAQ:IMCC) reported a 50% increase in Q3 2024 revenue for its German subsidiary, IMC Germany, compared to Q2. This growth highlights successful strategic initiatives and strong market demand.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:11 pm

BNTX

GOOG

GOOGL

Google DeepMind, part of Alphabet Inc., and BioNTech are collaborating to develop AI lab assistants to enhance scientific research. This partnership aims to revolutionize research by using AI to facilitate interdisciplinary collaboration and automate routine tasks, potentially boosting productivity and aiding in cancer treatment research.

Portfolio Pulse from Benzinga Neuro

October 02, 2024 | 12:11 pm

MARA

Marathon Digital Holdings (MARA) reported a 5% increase in its energized hash rate to 36.9 EH/s and a 5% growth in Bitcoin production to 705 BTC for September.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:10 pm